| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/01/2001 | WO2000058270A3 Hsv primase inhibitors |
| 03/01/2001 | WO2000046203A3 G-protein coupled heptahelical receptor binding compounds and methods of use thereof |
| 03/01/2001 | DE19939981A1 Neue Inhibitoren des Integrins alphavß3 New inhibitors of integrin alphavß3 |
| 03/01/2001 | DE19939980A1 Inhibitoren des Integrins alphavbeta¶3¶ Inhibitors of integrin alphavbeta¶3¶ |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | CA2382850A1 Novel inhibitors of the integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382779A1 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions |
| 03/01/2001 | CA2382561A1 Inhibitors of integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382311A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2376275A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 02/28/2001 | EP1078924A1 Intermediates and a process for producing beta-adrenergic receptor agonists |
| 02/28/2001 | EP1078920A1 Process for producing pyridine derivative through reaction of azametal lacyclo pentadiene with alkyne |
| 02/28/2001 | EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient |
| 02/28/2001 | EP1077957A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 02/28/2001 | EP1077943A1 Heterocyclic inhibitors of p38 |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077920A1 New compounds, their preparation and use |
| 02/28/2001 | EP1077919A1 New compounds, their preparation and use |
| 02/28/2001 | EP0792255B1 Liquid crystal compounds having perfluoroether terminal portions |
| 02/28/2001 | EP0706796B1 Dopamine re-uptake inhibitors for the treatment of parkinson's syndrome |
| 02/28/2001 | CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 02/28/2001 | CN1285818A Compound for antemortem diagnosis of alzheimer's disease and i(IN VIVO) imaging and prevention of amyloid deposition |
| 02/28/2001 | CN1062557C Recovery of 2,2'-combined dipyridine of atom transferred free radical polymeris |
| 02/28/2001 | CN1062555C Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 02/28/2001 | CN1062554C Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound |
| 02/27/2001 | US6194599 Process for preparing biaryl compounds |
| 02/27/2001 | US6194581 Substituted pyridines useful as modulators of acetylcholine receptors |
| 02/27/2001 | US6194575 Reacting 2-nitroimino-3,5-dimethyl-1,3, 5-triaza-cyclohexane derivative with urea in presence of diluent to form 1,3-di-substituted 2-nitroguanidine |
| 02/27/2001 | US6194574 Selectively bind to corticotropin-releasing factor (crf1) receptors; for treating stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety |
| 02/27/2001 | US6194451 Prevent release tumor necrosis factor; antiinflammatory agents |
| 02/27/2001 | US6194443 Aminophenol derivatives with fungicidal property |
| 02/27/2001 | US6194439 Tricyclic polyhydroxylic tyrosine kinase inhibitors |
| 02/27/2001 | US6194437 Non-peptide bombesin receptor antagonists |
| 02/27/2001 | US6194428 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system |
| 02/27/2001 | US6194425 Viricides, antitumor agents |
| 02/27/2001 | US6194418 Bactericides, pesticides |
| 02/27/2001 | US6194413 Hemoregulatory compounds |
| 02/27/2001 | US6194132 Photographic element, compound, and process |
| 02/27/2001 | CA2316662A1 Use of crf antagonists and related compositions |
| 02/27/2001 | CA2101316C Gnrh analogs |
| 02/22/2001 | WO2001012622A1 Piperidine and pyrrolidine derivatives displaying neuronal activity |
| 02/22/2001 | WO2001012615A2 Fungicidal heteroaryl hepta-2,6-dienoic acid derivatives |
| 02/22/2001 | WO2001012604A1 Fungicides |
| 02/22/2001 | WO2001012591A1 Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 02/22/2001 | WO2001012584A2 Pharmaceutical compounds |
| 02/22/2001 | WO2001012193A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO2001012180A2 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune responce |
| 02/22/2001 | WO2001011966A1 Fungicides |
| 02/22/2001 | WO2001011965A1 Fungicides |
| 02/22/2001 | WO2000071514A8 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
| 02/22/2001 | WO2000071500A8 Halogen compounds |
| 02/22/2001 | WO2000063177A8 Method of producing chloropyridine sulfonic acid chlorides |
| 02/22/2001 | WO2000059862A3 Processes for preparing pesticidal intermediates |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | DE19939645A1 New 1,3-bis(2,3-dihydroxybenzoylamino) substituted (hetero)aromatic siderophore compounds useful as bacterial growth factors and chemotherapeutic agents, e.g. for treatment of Alzheimer's disease |
| 02/22/2001 | DE19939516A1 New 1-carboxyalkyl-4-(hetero)aryl-piperazine derivatives, as microsomal triglyceride transfer protein inhibitors useful for reducing plasma atherogenic lipoprotein levels, e.g. in treatment of hyperlipidemia |
| 02/22/2001 | CA2698353A1 Pharmaceutical compounds |
| 02/22/2001 | CA2381409A1 Nitric ester derivatives |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/21/2001 | EP1076655A1 N-pyridonyl herbicides |
| 02/21/2001 | EP1076648A1 Method for the catalytic production of substituted dipyridyl derivatives |
| 02/21/2001 | EP1076644A1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 02/21/2001 | EP1076641A1 Inhibitors of impdh enzyme |
| 02/21/2001 | EP0983242A4 Method for producing particles of pyrithione salts |
| 02/21/2001 | CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 02/21/2001 | CN1284945A Substituted pyriding and pyridazine compounds and their pharmaceutical use |
| 02/21/2001 | CN1284944A Integrin receptor antagonists |
| 02/21/2001 | CN1284942A Matrix metalloprotease inhibitors |
| 02/21/2001 | CN1062268C Alcohol to azide SN2 conversion |
| 02/21/2001 | CN1062266C Amidine derivative and platelet agglutination inhibitor containing said amidine derivative |
| 02/21/2001 | CN1062265C Method for producing triazine derivatives |
| 02/20/2001 | US6191304 Vitronectin receptor antagonists |
| 02/20/2001 | US6191280 Method for producing substituted thiopyridines |
| 02/20/2001 | US6191277 Hydroxypropylamide peptidomimetics as inhibitors of aspartyl proteases |
| 02/20/2001 | US6191170 Benzenesulfonamides and benzamides as therapeutic agents |
| 02/20/2001 | US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 02/20/2001 | US6191157 Anticholesterol agents; cardiovascular disorders |
| 02/20/2001 | US6191149 Heterocyclic derivative and medicine |
| 02/20/2001 | US6191146 Hemoregulatory compounds |
| 02/20/2001 | US6191135 Respiratory system disorders, antiinflammatory agents; analgesics |
| 02/20/2001 | US6190850 Photographic element, compound, and process |
| 02/15/2001 | WO2001010875A1 Metal complexes comprising a 2,6-diacylpyridine-ligand and their use in the polymerization of ethylene |
| 02/15/2001 | WO2001010847A2 Novel integrin receptor antagonists |
| 02/15/2001 | WO2001010843A1 4-(substituted phenyl)-5-halopyrimidine derivatives and herbicides containing the same as the active ingredient |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010834A2 Antibacterial agents |
| 02/15/2001 | WO2001010827A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 02/15/2001 | WO2001010825A1 Carbamate derivatives and agricultural/horticultural bactericides |
| 02/15/2001 | WO2001010823A1 Carboxylic acid amides, their production and their use as drugs |
| 02/15/2001 | WO2001010441A1 Torsemide polymorphs |
| 02/15/2001 | WO2001010433A1 Neuropathy improvers containing nitrogenous compounds as the active ingredient |
| 02/15/2001 | WO2001010383A2 Caspase inhibitors and uses thereof |
| 02/15/2001 | WO2001010381A2 Methods for treating or preventing pain and anxiety |
| 02/15/2001 | WO2001010380A2 Benzanilides as potassium channel openers |